结论ACI患者血浆型PAF - AH基因9号外显子突变基因型及突变等位基因显著增高。

ConclusionThe prevalence of the mutation genotype and the mutation allele of PAFAH exon 9 in patients with ACI is significantly increased.

youdao

目的了解拉米夫定耐药与HBV基因型及HBV基本核心启动子(BCP)突变之间的关系。

Objective To investigate the relationship of HBV Lumivudine resistant and HBV genotypes and basic core promoter (BCP) mutation.

youdao

与野生基因型携带者相比较，突变杂合和突变纯合基因型携带者的子代罹患CHD的OR值为0.46 (95% CI： 0.31 ~ 0.69)。

Compared with wild type genotype, offsprings of mutant heterozygote and homozygote were at higher risk of CHD, with OR0.46 (95%ci: 0.31 ~ 0.69).

youdao